Clinical observation of capecitabine as first-line monotherapy in elderly patients with Ⅱa breast cancer

Journal Title: Di-er Junyi Daxue Xuebao - Year 2009, Vol 30, Issue 2

Abstract

Objective:To observe the clinical effect and adverse reaction of capecitabine as first-line monotherapy in elderly patients with stage Ⅱa breast cancer.Methods: From June 2002 to June 2005,71 elderly patients with stage Ⅱa breast cancer received chemotherapy(different scheme: capecitabine group and CEF group) after operation.The efficacies and adverse reactions were evaluated and compared between the two groups.Results: The 3-year and 5-year survival rates of patients in capecitabine group were 97.06% and 94.12%,respectively; the relapse rate was 5.88%; all were comparable to those of CEF group. One of the advantages of capecitabine was its oral administration. The adverse effect of capecitabine was mainly hand-foot syndrome,with an incidence of 82.35%,but was tolerable. The gastrointestinal reaction and bone marrow repression in capecitabine group were significantly lower than those in the CEF group(P<0.01). There was no giving up of treatment due to adverse reactions or fear of chemotherapy in our group. Conclusion: Capecitabine is effective and safe in the treatment of elderly patients with stage Ⅱa breast cancer; it is easy to take,with less adverse effects and better patient compliance.

Authors and Affiliations

Wei HU

Keywords

Related Articles

Pharmacokinetics of granisetron hydrocloride capsule in healthy volunteers

Objective:To establish a sensitive and specific LC/MS/MS method for the determination of granisetron in human plasma,and to apply it in investigating the pharmacokinetics of granisetron hydrocloride capsule in healthy vo...

Expression of chemokine receptor CXCR4 in hepatocellular carcinoma

Objective:To investigate the expression of chemokine receptor CXCR4 in hepatocellular carcinoma tissues,hepatocellular carcinoma cell line-MHCC97,human umbilical vein endothelial cells (HUVECs) and the ascites level of C...

抗PIWIL2蛋白多克隆抗体的制备、鉴定及初步应用

目的:制备兔抗人PIWIL2(P-element-induced wimpy testis like 2,或称HIWI2)的多克隆抗体,并鉴定其特异性,初步探讨其在人正常及肿瘤组织中的分布。方法:人工合成特异性PIWIL2多肽,以马来酰胺活化匙孔血蓝蛋白(Keyhole limpet hemocyanin,K...

Clinical observation of capecitabine as first-line monotherapy in elderly patients with Ⅱa breast cancer

Objective:To observe the clinical effect and adverse reaction of capecitabine as first-line monotherapy in elderly patients with stage Ⅱa breast cancer.Methods: From June 2002 to June 2005,71 elderly patients with stage...

Download PDF file
  • EP ID EP83031
  • DOI -
  • Views 115
  • Downloads 0

How To Cite

Wei HU (2009). Clinical observation of capecitabine as first-line monotherapy in elderly patients with Ⅱa breast cancer. Di-er Junyi Daxue Xuebao, 30(2), 187-189. https://europub.co.uk/articles/-A-83031